side-effects
side-effects predicts serious adverse drug reactions (ADRs) using compressed sensing applied to pharmacological datasets to improve pharmacovigilance and drug safety assessment.
Key Features:
- Compressed Sensing Framework: Employs compressed sensing to reconstruct sparse chemical–ADR association signals from incomplete, noisy, and biased ADR databases.
- Prediction Accuracy Improvement Over Time: Refines predictions for serious ADRs as additional ADR observations become available throughout clinical trial phases and from marketed drugs.
- Novel Chemical–ADR Associations: Infers previously undocumented associations between chemicals and adverse reactions by analyzing existing pharmacological datasets.
- Large-Scale Sparse Data Handling: Suited for large-scale datasets characterized by sparsity and noise typical of ADR databases.
Scientific Applications:
- Pharmacovigilance: Prioritizes potential serious ADRs for surveillance and signal detection in post-market and clinical data.
- Drug Development: Supports safety assessment of candidate drugs by predicting serious ADRs during clinical development.
- Regulatory Decision-Making: Informs regulatory risk evaluation and safety profiling for drug approval and labeling decisions.
Methodology:
Integrates existing pharmacological and ADR datasets with compressed sensing techniques to reconstruct sparse chemical–ADR signals from incomplete and noisy data and to infer associations and refine predictions as additional ADR observations are incorporated.
Topics
Details
- Tool Type:
- library
- Operating Systems:
- Linux, Windows, Mac
- Programming Languages:
- MATLAB
- Added:
- 6/2/2018
- Last Updated:
- 11/25/2024
Operations
Publications
Poleksic A, Xie L. Predicting serious rare adverse reactions of novel chemicals. Bioinformatics. 2018;34(16):2835-2842. doi:10.1093/bioinformatics/bty193. PMID:29617731. PMCID:PMC6084596.
PMID: 29617731
PMCID: PMC6084596
Funding: - National Institute of Health: R01GM122845, R01LM011986
- National Science Foundation: ACI-1126113, CNS-0855217, CNS-0958379